Clinical Trial Manager
About the Company
Braveheart Bio is a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. Our lead product candidate, BHB-1893, is a next-generation oral small-molecule cardiac myosin inhibitor (CMI) being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM). Braveheart’s goal is to improve the treatment options for these patients by enhancing speed of onset, depth of gradient response, systolic safety, reversibility and reducing prescribing complexity. With a proven leadership team, a strong financial foundation, and a high-value late-stage asset, Braveheart Bio represents an outstanding opportunity for ambitious, mission-driven professionals to make a tangible impact in a high-profile and rapidly evolving therapeutic area.
About the Role
The Clinical Trial Manager (CTM) is a key member of the Clinical Operations team and will report into the Clinical Program Manager, Clinical Operations, partnering closely on the start-up and initiation of a global Phase 3 program. The primary responsibilities of the CTM will be regional study management of the EU and vendor management.
Responsibilities
- With guidance